Regenerative Medicine: Promises and Challenges in the Treatment of Musculoskeletal Conditions
Wednesday, October 24
8 am-5 pm
Course Directors: Gerald A. Malanga, MD, FAAPMR and Prathap Jayaram MD, FAAPMR
Faculty: Joanne Borg-Stein, MD, FAAPMR; Jay E. Bowen, DO, FAAPMR; Kenneth Mautner, MD, FAAPMR; William F. Micheo, MD, FAAPMR; Imran J. Siddiqui, MD
Regenerative medicine has been a recent clinical advancement in addressing the unmet need in orthopedic injury. There have been significant clinical and basic science advancements in technology and delivery strategy. This course brings together leading experts to discuss these advancements across multiple domains including stem cell-derived therapies, autologous blood-derived therapies, and gene transfer strategies.
Upon completion of this course, participants will be able to:
- Recognize and apply general principles in choosing the appropriate regenerative treatment for musculoskeletal conditions.
- Explain the basic science of platelet-rich plasma and stem cell therapies in the treatment of degenerative musculoskeletal conditions.
- Define the current FDA position regarding the use of stem cell and platelet-rich plasma therapies and the restrictions in the use of these treatments in clinical practice.
- Explain the current clinical evidence to support the use of platelet-rich plasma and mesenchymal cell treatment.
- Assess and implement appropriate staffing and equipment needs to perform platelet-rich plasma and stem cell therapies.
- Acquire the skills and outline the steps to harvest platelets and stem cells from bone marrow and adipose tissue, including appropriate sterile techniques, proper anesthesia and pain control as well as recognize the risks of these procedures.
- Determine the basic skill set required to perform stem cell therapies, including appropriate history and physical examination, anatomical surface anatomy, and radiographic and ultrasound anatomy.
- Recognize the appropriate skill set needed for performing image (fluoroscopic or ultrasound) guided injections.
A Word From Our Course Directors
We invite practitioners, who seek an understanding of the latest technologies and applications in the rapidly-evolving field of regenerative medicine, to increase their knowledge and expertise in this exciting area of medicine. Learn from leading experts how regenerative interventions can be optimized in the treatment of degenerative musculoskeletal conditions.
— Drs. Jayaram and Malanga
Who Should Attend?
Physicians who wish to advance their knowledge of regenerative treatment options and how to begin to incorporate these treatments into their practice. This course is offered only to doctors of medicine or doctors of osteopathy.
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The American Academy of Physical Medicine and Rehabilitation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Lecture Topics Include:
- Rationale for regenerative interventions in orthopedics and sports medicine
- Status of and utility in prolotherapy in a regenerative clinical practice
- Basic terminology in Regenerative/Stem Cell Therapies: The ABCs of stem cell language
- Current applications of platelet-rich plasma
- Adipose vs bone marrow-derived stem cell therapies
- Orthobiologic treatments for spine pain
- Technical issues in harvesting and concentrating stem cells
- Regulatory issues in regenerative orthopedics
Academy Tested, Board Approved!
The 2018 Annual Assembly Preconference Courses have been approved by the American Board of Physical Medicine and Rehabilitation (ABPMR) for Maintenance of Certification® (MOC®) Part II Self-Assessment credit. Attendees must complete a post-test to earn AMA PRA Category 1 Credits™, which will be commensurate with the number of CME available for each precourse.
Content and faculty subject to change.